Abstract
According to the latest European guidelines on the management of nonvalvular atrial fibrillation (NVAF), all patients aged ≥ 65 years should be treated with oral anticoagulation (if not contraindicated). Therefore, stroke risk factors should be investigated exclusively in patients with NVAF aged <65 years.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Chest |
Vol/bind | 141 |
Udgave nummer | 1 |
Sider (fra-til) | 147-53 |
Antal sider | 7 |
ISSN | 0012-3692 |
DOI | |
Status | Udgivet - 2012 |